Moleculin Biotech Inc (MBRX) stock news · $8.2M cap
Moleculin Biotech Inc (MBRX) is a biotechnology company listed on US.
This MBRX news page leads with what Moleculin Biotech Inc filed — not a scraped headline mill.
No cached 8-K sentence for MBRX yet. We will not pad this page with generic market recap.
Latest reported MBRX revenue for 2025-12-31 was $0. Net income was -$33.6M. MBRX currently screens at market cap $8.2M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the MBRX stock page; for the tape open the quote page.
MBRX stock news FAQ
What is MBRX's latest net income?
Latest cached Moleculin Biotech Inc (MBRX) net income was -$33.6M. Statements: https://lician.com/financials/mbrx
What is MBRX's market cap?
Moleculin Biotech Inc (MBRX) market cap is $8.2M on the latest cached fundamentals snapshot.
What kind of company is MBRX?
Moleculin Biotech Inc (MBRX) is a biotechnology company listed on US.
Where is MBRX stock news listed?
Cached stock news for Moleculin Biotech Inc (MBRX) is listed at https://lician.com/news/mbrx. Filings: https://lician.com/sec/mbrx
Not investment advice.